In the final stop of this tour de force of study, the authors demonstrated as a proof-of-principle of therapeutic potential that local delivery of IL-33 and CCL5 (separately) enhanced bone mass and function in the OVX rat model for osteoporosis.5 This evidence concerns the gene IL33 and osteoporosis.